The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
rac-(5-Bromo-1-methyl-1H-pyrrolo[2,3-c]pyridin-2-yl){6-[(dimethylamino)methyl]-3-methyl-3,4-dihydroisoquinolin-2(1H)-yl}methanone ID: ALA3314360
PubChem CID: 118707560
Max Phase: Preclinical
Molecular Formula: C22H25ClN4O
Molecular Weight: 396.92
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC1Cc2cc(CN(C)C)ccc2CN1C(=O)c1cc2cc(Cl)ncc2n1C
Standard InChI: InChI=1S/C22H25ClN4O/c1-14-7-17-8-15(12-25(2)3)5-6-16(17)13-27(14)22(28)19-9-18-10-21(23)24-11-20(18)26(19)4/h5-6,8-11,14H,7,12-13H2,1-4H3
Standard InChI Key: XFVPHPQDPXRAFQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
4.3152 -3.0999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3140 -3.9273 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0288 -4.3401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0270 -2.6872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7424 -3.0963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7427 -3.9227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5287 -4.1779 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0144 -3.5091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5283 -2.8408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7839 -4.9624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8394 -3.5088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2521 -4.2231 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.2516 -2.7942 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.8346 -4.9381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2438 -5.6503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0727 -4.2214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4836 -4.9398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0692 -5.6520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4788 -6.3649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3026 -6.3666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7151 -5.6496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3031 -4.9398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7149 -7.0812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5399 -7.0815 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.9522 -7.7961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9526 -6.3671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6006 -2.6876 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
7.4181 -4.2168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
8 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
12 16 1 0
14 15 1 0
15 18 1 0
17 16 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
20 23 1 0
23 24 1 0
24 25 1 0
24 26 1 0
1 27 1 0
14 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 396.92Molecular Weight (Monoisotopic): 396.1717AlogP: 3.88#Rotatable Bonds: 3Polar Surface Area: 41.37Molecular Species: BASEHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.79CX LogP: 3.24CX LogD: 1.84Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.63Np Likeness Score: -1.24
References 1. Georgsson J, Bergström F, Nordqvist A, Watson MJ, Blundell CD, Johansson MJ, Petersson AU, Yuan ZQ, Zhou Y, Kristensson L, Kakol-Palm D, Tyrchan C, Wellner E, Bauer U, Brodin P, Svensson Henriksson A.. (2014) GPR103 antagonists demonstrating anorexigenic activity in vivo: design and development of pyrrolo[2,3-c]pyridines that mimic the C-terminal Arg-Phe motif of QRFP26., 57 (14): [PMID:24937104 ] [10.1021/jm401951t ] 2. Georgsson, Jennie J and 15 more authors. 2014-07-24 GPR103 antagonists demonstrating anorexigenic activity in vivo: design and development of pyrrolo[2,3-c]pyridines that mimic the C-terminal Arg-Phe motif of QRFP26. [PMID:24937104 ]